A Phase 2 Study of AZD6244 in Multiple Myeloma.

Trial Profile

A Phase 2 Study of AZD6244 in Multiple Myeloma.

Phase of Trial: Phase II

Latest Information Update: 07 Oct 2015

At a glance

  • Drugs Selumetinib (Primary)
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 07 Oct 2015 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research.
    • 22 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top